Sharma Ravinder, Gupta Vikas, Parashar Bharat, Chawla Viney, Chawla Pooja A
Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, The ICFAI University, Baddi, Himachal Pradesh, India.
Department of Pharmacy,University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, Punjab, India.
Curr Med Chem. 2024 Oct 17. doi: 10.2174/0109298673316661241002060518.
Methicillin-resistant Staphylococcus aureus [MRSA] stands as an enduring threat within healthcare landscapes, characterized by its ability to rapidly evolve and develop resistance to conventional antibiotics. This comprehensive review embarks on a journey through the historical landscape of MRSA, elucidating its initial emergence and subsequent evolution of resistance mechanisms over time. The narrative unfolds to underscore the profound impact of MRSA on patient outcomes and healthcare systems globally. Current trends in MRSA therapies come under meticulous scrutiny, spotlighting the limitations and challenges associated with existing treatment modalities. This analysis underscores the critical need for transformative and innovative therapeutic strategies to effectively combat the ever-growing spectre of drug resistance in MRSA from the exploration of novel antibiotics designed to overcome resistance mechanisms to the promising potential of phage therapy and immunotherapies. Amidst the exploration of innovative therapies, the review identifies and discusses emerging issues and challenges in MRSA management. Insights are provided into the intricate web of obstacles hindering the adoption and implementation of new therapeutic strategies. Furthermore, the socio-economic implications of MRSA and drug resistance are brought to the forefront, emphasizing the broader impact on public health and healthcare systems. In parallel, historical perspectives on MRSA research illuminate key milestones in scientific understanding and technological advancements. The evolution of research strategies and their impact on our ability to comprehend and combat MRSA is examined, providing context for the current state of the field. In conclusion, this review summarizes major findings and drawing implications for the future of MRSA treatment. Recommendations for further research and clinical practice are outlined, encapsulating a holistic overview of the resilient efforts against resistance in the ongoing battle against MRSA.
耐甲氧西林金黄色葡萄球菌(MRSA)在医疗环境中一直是个持久的威胁,其特点是能够迅速进化并对传统抗生素产生耐药性。这篇全面综述回顾了MRSA的历史,阐明了其最初出现以及耐药机制随时间的演变。叙述过程强调了MRSA对全球患者预后和医疗系统的深远影响。对MRSA治疗的当前趋势进行了细致审查,突出了现有治疗方式的局限性和挑战。这一分析强调了迫切需要变革性和创新性治疗策略,以有效应对MRSA日益增长的耐药问题,从探索旨在克服耐药机制的新型抗生素到噬菌体疗法和免疫疗法的潜在前景。在探索创新疗法的过程中,综述确定并讨论了MRSA管理中出现的新问题和挑战。深入探讨了阻碍新治疗策略采用和实施的错综复杂的障碍。此外,还突出了MRSA和耐药性的社会经济影响,强调了对公共卫生和医疗系统的更广泛影响。同时,MRSA研究的历史视角揭示了科学认识和技术进步的关键里程碑。研究了研究策略的演变及其对我们理解和对抗MRSA能力的影响,为该领域的现状提供了背景。总之,本综述总结了主要发现,并对MRSA治疗的未来提出了启示。概述了进一步研究和临床实践的建议,全面概述了在与MRSA的持续斗争中对抗耐药性的不懈努力。